RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,640.00
-3.95 (-0.15%)
BSENSE

Aug 11

BSE+NSE Vol: 7.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Innova Captab
Novartis India
IOL Chemicals
Bliss GVS Pharma
Morepen Labs.
Gufic BioScience
RPG LifeScience.
Aarti Drugs
FDC
Guj. Themis Bio.
Zota Health Care
Why is RPG Life Sciences Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.70% over the last 5 years
2
Flat results in Mar 26
  • ROCE(HY) Lowest at 24.18%
  • PBT LESS OI(Q) At Rs 26.74 cr has Fallen at -9.3% (vs previous 4Q average)
3
Despite the size of the company, domestic mutual funds hold only 0.15% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to RPG LifeScience. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is RPG LifeScience. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
RPG LifeScience.
15.19%
0.09
37.21%
Sensex
-3.04%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.60%
EBIT Growth (5y)
17.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
1.53
Tax Ratio
25.33%
Dividend Payout Ratio
21.66%
Pledged Shares
0
Institutional Holding
9.63%
ROCE (avg)
41.11%
ROE (avg)
20.40%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
37
Industry P/E
37
Price to Book Value
7.21
EV to EBIT
31.17
EV to EBITDA
26.70
EV to Capital Employed
10.78
EV to Sales
5.65
PEG Ratio
1.62
Dividend Yield
0.91%
ROCE (Latest)
32.66%
ROE (Latest)
19.27%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
PAT(Q)

Highest at Rs 30.76 cr.

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 156.78 cr

NET SALES(Q)

Highest at Rs 195.69 cr

PBDIT(Q)

Highest at Rs 43.29 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 22.12%

PBT LESS OI(Q)

Highest at Rs 36.76 cr.

-3What is not working for the Company
ROCE(HY)

Lowest at 24.18%

Loading Valuation Snapshot...
Here's what is working for RPG LifeScience.
Profit After Tax (PAT) - Quarterly
Highest at Rs 30.76 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 195.69 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 43.29 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 22.12%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 36.76 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 156.78 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents